TILT News | Roxom Stocks

1 BTC

=

- USD

Loading market data...

TI

AUM

N/A

Volume

997

Yield

1.06%

Chart Earnings News About Dividends Insider Filings

Is Northern Trust Morningstar US Market Factor Tilt ETF (TILT) a Strong ETF Right Now?TILT is a smart beta ETF with $2.2 billion in assets that tilts toward small-cap and value stocks. With a 0.25% expense ratio and 1,911 holdings, it has delivered 13.27% YTD and 16.11% one-year returns as of October 5, 2026. The fund carries medium risk with a beta of 1.01 and is heavily weighted toward technology (31.2%), with top holdings including NVDA, AAPL, and MSFT. Cheaper alternatives like ITOT and VTI are also available for investors.Zacks Investment Research · Oct 5, 2026

Global Bispecific Antibody Market Size Bispecific Antibodies Sales FDA Approved Bispecific Antibodies Market ForecastThe global bispecific antibody market is experiencing significant growth, with the market size expected to surpass $40 billion by 2030. The market is driven by the approval of 14 bispecific antibodies, including Hemlibra and Vabysmo, which have emerged as market leaders. The US remains the largest regional contributor, accounting for over 60% of the total sales in 2023.GlobeNewswire Inc. · Oct 4, 2024

The More Things Stay The SameOne of the cardinal tenets of investment management is that nothing stays the same forever.Seeking Alpha · May 11, 2024

Is FlexShares Morningstar U.S. Market Factor Tilt ETF (TILT) a Strong ETF Right Now?Smart Beta ETF report for TILTZacks Investment Research · May 6, 2024

Is FlexShares Morningstar U.S. Market Factor Tilt ETF (TILT) a Strong ETF Right Now?Smart Beta ETF report for TILTZacks Investment Research · Mar 6, 2024

Magnificent Seven Drive 2023 U.S. Large Caps - And Spotlight Index Profitability RulesThe rise of the Magnificent Seven marks a shift in the type of company that grows to become a mega cap.Seeking Alpha · Feb 3, 2024

Is FlexShares Morningstar U.S. Market Factor Tilt ETF (TILT) a Strong ETF Right Now?Smart Beta ETF report for TILTZacks Investment Research · Jan 2, 2024

Is FlexShares Morningstar U.S. Market Factor Tilt ETF (TILT) a Strong ETF Right Now?Smart Beta ETF report for TILTZacks Investment Research · Nov 1, 2023

High Capex, High Rewards: Analyst Looks At Cannabis MSOs' StrategiesAs interest rates climb and regulatory uncertainties loom, decisions on capital expenditures (capex) by cannabis MSOs (Multi-State Operators) become paramount for their future success. Are some MSOs missing out on significant growth opportunities? In his latest analysis, Pablo Zuanic, managing partner and senior analyst at Zuanic & Associates, delves into the world of capital expenditure (capex) in the context of 20 prominent MSOs. Charting the Growth Path: A Closer Look at Capex Strategies and Their Impact Zuanic highlights that, amid high interest rates and regulatory uncertainties, most companies are prioritizing cost reduction and cash flow management, but suggests that some MSOs with the resources should seize the opportunity to increase capex for profitable growth. "Given the macro context, high interest rates, and regulatory uncertainty, it makes sense that most companies are more focused on cutting costs and managing cash flow. On the other hand, this is precisely the time for some MSOs to take advantage (if they have the resources to do so), and ramp capex in the pursuit of profitable growth," Zuanic wrote. High Capex to Sales Green Thumb (OTC: GTBIF) Leads the Way: Green Thumb, with a capex-to-sales ratio of 26% in 1H23, stands out as the leader in this ...Full story available on Benzinga.comBenzinga · Oct 18, 2023

Is FlexShares Morningstar U.S. Market Factor Tilt ETF (TILT) a Strong ETF Right Now?Smart Beta ETF report for TILTZacks Investment Research · Jun 5, 2023

TI

TILTNorthern Trust Morningstar US Market Factor Tilt ETF

TILT

Pay with—

Available Balance0.00

Your PositionYou don't own any TILT yet.

Related Tickers

Earnings

Dividends

Last · Sep 18Quarterly

Amount$0.74

Yield1.07%

Annual$2.99